Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Genital Herpes Treatment

>>

North America Genital Herpes Treatment Market


North America Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Country: Trend Forecast and Growth Opportunity

Report code: SDMRGE1688823 | Industry: Genital Herpes Treatment | Published On: 44985


North America genital herpes treatment market is projected to grow by 3.9% annually in the forecast period and reach $1,650.9 million by 2032, driven by the rising prevalence of sexually transmitted diseases, changing socio-cultural openness, increasing awareness about HSV infection and its symptoms, improved access to antiviral medications, and the government supports.
Highlighted with 25 tables and 44 figures, this 107-page report “North America Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire North America genital herpes treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America genital herpes treatment market in every aspect of the classification from perspectives Virus, Drug Type, Route of Administration, Patient Gender, Distribution Channel, and Country.

Based on Virus Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• HSV-1
• HSV-2

Based on Drug Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Acyclovir
• Valacyclovir
• Famciclovir
• Other Drugs

By Route of Administration, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Oral
• Topical
• Injection

By Patient Gender, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Female
• Male

By Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Drug Stores

Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Virus Type, Drug Type and Distribution Channel over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott
ADLEY FORMULATIONS
Aurobindo Pharma Ltd.
Avet Pharmaceuticals Inc.
Bausch Health Companies
Centurion Remedies
Cipla Ltd.
Eli Lilly & Company
Finecure Pharmaceuticals
GlaxoSmithKline Plc
Glenmark Pharmaceuticals
Macleods Pharmaceuticals
Medico Remedies
Merck & Co., Inc.
Novartis AG
Pfizer
Reddy's Laboratories
Sanofi SA
Teva Pharmaceutical Industries Ltd.
Torrent Pharma
Viatris Inc.
Zeelab Pharmacy
Zydus Pharmaceuticals, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1  Introduction 7
1.1  Industry  Definition  and  Research  Scope 7
1.1.1  Industry  Definition 7
1.1.2  Research  Scope 8
1.2  Research  Methodology 11
1.2.1  Overview  of  Market  Research  Methodology 11
1.2.2  Market  Assumption 12
1.2.3  Secondary  Data 12
1.2.4  Primary  Data 12
1.2.5  Data  Filtration  and  Model  Design 13
1.2.6  Market  Size/Share  Estimation 14
1.2.7  Research  Limitations 15
1.3  Executive  Summary 16
2  Market  Overview  and  Dynamics 19
2.1  Market  Size  and  Forecast 19
2.1.1  Impact  of  COVID-19  on  World  Economy 20
2.1.2  Impact  of  COVID-19  on  the  Market 23
2.2  Major  Growth  Drivers 25
2.3  Market  Restraints  and  Challenges 29
2.4  Emerging  Opportunities  and  Market  Trends 32
2.5  Porter’s  Fiver  Forces  Analysis 36
3  Segmentation  of  North  America  Market  by  Virus  Type 40
3.1  Market  Overview  by  Virus  Type 40
3.2  HSV-1 42
3.3  HSV-2 43
4  Segmentation  of  North  America  Market  by  Drug  Type 44
4.1  Market  Overview  by  Drug  Type 44
4.2  Acyclovir 47
4.3  Valacyclovir 48
4.4  Famciclovir 49
4.5  Other  Drugs 50
5  Segmentation  of  North  America  Market  by  Route  of  Administration 52
5.1  Market  Overview  by  Route  of  Administration 52
5.2  Oral 54
5.3  Topical 55
5.4  Injection 56
6  Segmentation  of  North  America  Market  by  Patient  Gender 57
6.1  Market  Overview  by  Patient  Gender 57
6.2  Female 59
6.3  Male 60
7  Segmentation  of  North  America  Market  by  Distribution  Channel 61
7.1  Market  Overview  by  Distribution  Channel 61
7.2  Retail  Pharmacies 63
7.3  Hospital  Pharmacies 64
7.4  Online  Pharmacies 65
7.5  Drug  Stores 66
8  North  America  Market  2022-2032  by  Country 67
8.1  Overview  of  North  America  Market 67
8.2  U.S. 70
8.3  Canada 75
8.4  Mexico 77
9  Competitive  Landscape 79
9.1  Overview  of  Key  Vendors 79
9.2  New  Product  Launch,  Partnership,  Investment,  and  M&A 82
9.3  Company  Profiles 83
Abbott 83
ADLEY  FORMULATIONS 85
Aurobindo  Pharma  Ltd. 86
Avet  Pharmaceuticals  Inc. 87
Bausch  Health  Companies 88
Centurion  Remedies 89
Cipla  Ltd. 90
Eli  Lilly  &  Company 91
Finecure  Pharmaceuticals 92
GlaxoSmithKline  Plc 93
Glenmark  Pharmaceuticals 94
Macleods  Pharmaceuticals 95
Medico  Remedies 96
Merck  &  Co.,  Inc. 97
Novartis  AG 98
Pfizer 99
Reddy's  Laboratories 100
Sanofi  SA 101
Teva  Pharmaceutical  Industries  Ltd. 102
Torrent  Pharma 103
Viatris  Inc. 104
Zeelab  Pharmacy 105
Zydus  Pharmaceuticals,  Inc. 106
RELATED  REPORTS 107
List of Tables:

Table 1. Snapshot of North America Genital Herpes Treatment Market in Balanced Perspective, 2022-2032 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. World Health Spending by Region, $ bn, 2013-2020 28
Table 5. Main Product Trends and Market Opportunities in North America Genital Herpes Treatment Market 32
Table 6. North America Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn 40
Table 7. North America Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn 44
Table 8. Side Effects of Genital Herpes Medications 44
Table 9. Vaccine Pipelines for Herpes 51
Table 10. North America Genital Herpes Treatment Market by Route of Administration, 2022-2032, $ mn 52
Table 11. North America Genital Herpes Treatment Market by Patient Gender, 2022-2032, $ mn 57
Table 12. North America Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn 61
Table 13. North America Genital Herpes Treatment Market by Country, 2022-2032, $ mn 68
Table 14. U.S. Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn 74
Table 15. U.S. Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn 74
Table 16. U.S. Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn 74
Table 17. Canada Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn 76
Table 18. Canada Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn 76
Table 19. Canada Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn 76
Table 20. Mexico Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn 78
Table 21. Mexico Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn 78
Table 22. Mexico Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn 78
Table 23. Abbott: Company Snapshot 83
Table 24. Abbott: Business Segmentation 84
Table 25. Abbott: Product Portfolio 84
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT